Víctor H. Jiménez‐Zepeda

Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis

Joseph Mıkhael, Steven R. Schuster, Víctor H. Jiménez‐Zepeda et al. · Blood · 2012 · 373 citations · Full text

Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia

Esteban Braggio, Jonathan J. Keats, Xavier Leleu et al. · Cancer Research · 2009 · 148 citations · Full text

Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival

Víctor H. Jiménez‐Zepeda, Joseph Mıkhael, Andrew Winter et al. · Biology of Blood and Marrow Transplantation · 2011 · 115 citations · Full text

Progressive Multiple Myeloma, Cell Therapy, Immunology +19

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents

Christine I. Chen, Esther Masih‐Khan, Haiyan Jiang et al. · British Journal of Haematology · 2013 · 114 citations · Full text

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Oana Madalina Mereuta, Jason D. Theis, Julie A. Vrana et al. · Blood · 2014 · 87 citations